Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Children's Hospital of Philadelphia
Children's Hospital of Philadelphia
Boston Children's Hospital
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Stanford University
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Baylor College of Medicine
University of Texas Southwestern Medical Center
Columbia University
Hospital Universitari Vall d'Hebron Research Institute
University of California, San Francisco
New York Medical College
Emory University
Office of Rare Diseases (ORD)